Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Glycerol
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.198
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / LDL-cholesterol
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.00387
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.315
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Free fatty acids
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0682
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Triglycerides
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.441
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Total cholesterol
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.307
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Fasted Clinical Chemistry / Glucose
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0635
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.123
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0746
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.393
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.000188
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.889
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Heat Production (Metabolic Rate)
|
HOM
|
192f:511m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Oxygen consumption
|
HOM
|
192f:511m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
IPGTT / Blood glucose concentration
|
HOM
|
35f:35m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.544
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Potassium
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.327
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Sodium
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0579
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatinine
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.127
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Urea
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.252
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glucose
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0184
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
DEXA / Fat/Body weight
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000594
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.0865
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.0801
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.406
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
DEXA / Fat mass
|
HOM
|
7f:7m
|
Linear Mixed Model framework, LME, not including Weight
|
0.000950
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
4f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0691
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.216
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Calorimetry / Carbon dioxide production
|
HOM
|
f:336m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.127
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Calorimetry / Oxygen consumption
|
HOM
|
f:336m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Calorimetry / Heat production (metabolic rate)
|
HOM
|
f:336m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.400
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total cholesterol
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.647
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Creatine kinase
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.155
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00112
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.249
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.117
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.868
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.0880
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00815
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
4f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0415
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00449
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.0863
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
4f:3m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.283
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Free fatty acid
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0574
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Triglyceride
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.0694
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Dexa-scan analysis / Fat Mass
|
HOM
|
7f:6m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00465
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Chloride
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0225
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total protein
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.766
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Magnesium
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.310
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Albumin
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0361
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Calcium
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0633
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Calorimetry / Cumulative food intake
|
HOM
|
f:336m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Fructosamine
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, including Weight
|
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Phosphorus
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.650
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Iron
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0621
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Lactate dehydrogenase
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0119
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / LDL-cholesterol
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.168
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.897
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.882
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.655
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Total bilirubin
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.707
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
2.67×10-05
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Alpha-amylase
|
HOM
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.289
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Uric acid
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0422
|
Successful |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Dysmorphology / Body fat distribution
|
HOM
|
7f:7m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Indirect Calorimetry / Cumulative food intake
|
HOM
|
192f:511m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
1f:m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
f:1m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
2f:3m
|
|
|
NotProcessed |
Plekhm2tm1a(EUCOMM)Wtsi
|
WTSI
|
Clinical Chemistry / Glycerol
|
HOM
|
4f:3m
|
Linear Mixed Model framework, LME, including Weight
|
0.0160
|
Successful |